Treatment of migraine with monoclonal antibodies-Reference-Cited by-同舟云学术

Treatment of migraine with monoclonal antibodies

Published:2022-05-13 Issue:6 Volume:22 Page:707-716
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Serra López-Matencio José María¹,Gago-Veiga Ana Beatriz²,Gómez Manuel³,Alañón Plaza Estefanía¹,Mejía Gina Paola⁴,González-Gay Miguel Ángel⁵,Castañeda Santos⁶⁷

Affiliation:

1. Hospital Pharmacy Division, Hospital Universitario de La Princesa, Madrid, Spain

2. Neurology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain

3. Methodology Unit, Health Research Institute Princesa (IIS-IP), Madrid, Spain

4. Pharmacology Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain

5. Rheumatology Division, Hospital Universitario Marqués de Valdecilla, University of Cantabria, Santander, Spain

6. Rheumatology Division, Hospital Universitario de La Princesa, Madrid, Spain

7. Medicine Department, Universidad Autónoma de Madrid (UAM) and Catedra, Madrid, Spain

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2022.2072207

Reference68 articles.

1. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019

2. Direct cost and healthcare resource utilization of patients with migraine before treatment initiation with calcitonin gene-related peptide monoclonal antibodies by the number of prior preventive migraine medication classes

3. Migraine is first cause of disability in under 50s: will health politicians now take notice?

4. My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed

5. Rapid referral for headache management from emergency department to headache centre: four years data

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience;The Journal of Headache and Pain;2024-04-29

2. Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein;Biochemistry;2024-04-11

3. RE‐START: Exploring the effectiveness of anti‐calcitonin gene‐related peptide resumption after discontinuation in migraine;European Journal of Neurology;2024-01-25

4. Headache Education by E-Learning Through Social Networking Services (Social Media);Journal of Healthcare Leadership;2023-11

5. Acute and prophylactic treatment of migraine;Canadian Primary Care Today;2023-06-14